BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29424951)

  • 1. Synthesis and Biological Evaluation of Fluorescent Bryostatin Analogues.
    Cummins TJ; Kedei N; Czikora A; Lewin NE; Kirk S; Petersen ME; McGowan KM; Chen JQ; Luo X; Johnson RC; Ravichandran S; Blumberg PM; Keck GE
    Chembiochem; 2018 Apr; 19(8):877-889. PubMed ID: 29424951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.
    Kedei N; Telek A; Michalowski AM; Kraft MB; Li W; Poudel YB; Rudra A; Petersen ME; Keck GE; Blumberg PM
    Biochem Pharmacol; 2013 Feb; 85(3):313-24. PubMed ID: 23146662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
    Thangsunan P; Tateing S; Hannongbua S; Suree N
    J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships.
    Kedei N; Kraft MB; Keck GE; Herald CL; Melody N; Pettit GR; Blumberg PM
    J Nat Prod; 2015 Apr; 78(4):896-900. PubMed ID: 25808573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line.
    Kedei N; Telek A; Czap A; Lubart ES; Czifra G; Yang D; Chen J; Morrison T; Goldsmith PK; Lim L; Mannan P; Garfield SH; Kraft MB; Li W; Keck GE; Blumberg PM
    Biochem Pharmacol; 2011 Jun; 81(11):1296-308. PubMed ID: 21458422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function.
    Keck GE; Kraft MB; Truong AP; Li W; Sanchez CC; Kedei N; Lewin NE; Blumberg PM
    J Am Chem Soc; 2008 May; 130(21):6660-1. PubMed ID: 18452293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [3H]bryostatin 4 to protein kinase C.
    Lewin NE; Dell'Aquila ML; Pettit GR; Blumberg PM; Warren BS
    Biochem Pharmacol; 1992 May; 43(9):2007-14. PubMed ID: 1596288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.
    Dell'Aquila ML; Herald CL; Kamano Y; Pettit GR; Blumberg PM
    Cancer Res; 1988 Jul; 48(13):3702-8. PubMed ID: 3132318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.
    Keck GE; Poudel YB; Welch DS; Kraft MB; Truong AP; Stephens JC; Kedei N; Lewin NE; Blumberg PM
    Org Lett; 2009 Feb; 11(3):593-6. PubMed ID: 19113896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Chromane-Based Bryostatin Analogues Prepared via Hydrogen-Mediated C-C Bond Formation: Potency Does Not Confer Bryostatin-like Biology.
    Ketcham JM; Volchkov I; Chen TY; Blumberg PM; Kedei N; Lewin NE; Krische MJ
    J Am Chem Soc; 2016 Oct; 138(40):13415-13423. PubMed ID: 27676096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.
    Kedei N; Lewin NE; Géczy T; Selezneva J; Braun DC; Chen J; Herrmann MA; Heldman MR; Lim L; Mannan P; Garfield SH; Poudel YB; Cummins TJ; Rudra A; Blumberg PM; Keck GE
    ACS Chem Biol; 2013 Apr; 8(4):767-77. PubMed ID: 23369356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.
    Kelsey JS; Cataisson C; Chen J; Herrmann MA; Petersen ME; Baumann DO; McGowan KM; Yuspa SH; Keck GE; Blumberg PM
    Mol Carcinog; 2016 Dec; 55(12):2183-2195. PubMed ID: 26859836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells.
    Sako T; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
    Cancer Res; 1987 Oct; 47(20):5445-50. PubMed ID: 2888531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells.
    Kedei N; Lubart E; Lewin NE; Telek A; Lim L; Mannan P; Garfield SH; Kraft MB; Keck GE; Kolusheva S; Jelinek R; Blumberg PM
    Chembiochem; 2011 May; 12(8):1242-51. PubMed ID: 21542090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bryostatin 1 A-ring acetate is not the critical determinant for antagonism of phorbol ester-induced biological responses.
    Keck GE; Li W; Kraft MB; Kedei N; Lewin NE; Blumberg PM
    Org Lett; 2009 Jun; 11(11):2277-80. PubMed ID: 19419164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core.
    Kraft MB; Poudel YB; Kedei N; Lewin NE; Peach ML; Blumberg PM; Keck GE
    J Am Chem Soc; 2014 Sep; 136(38):13202-8. PubMed ID: 25207434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological evaluation of indolactams for in vitro bryostatin 1-like activity.
    Tran U; Billingsley KL
    Bioorg Med Chem Lett; 2024 Jan; 97():129570. PubMed ID: 38036273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluation of Several Bryostatin Analogues Bearing a Diacylglycerol Lactone C-Ring.
    Baumann DO; McGowan KM; Kedei N; Peach ML; Blumberg PM; Keck GE
    J Org Chem; 2016 Sep; 81(17):7862-83. PubMed ID: 27494208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro.
    DeChristopher BA; Loy BA; Marsden MD; Schrier AJ; Zack JA; Wender PA
    Nat Chem; 2012 Sep; 4(9):705-10. PubMed ID: 22914190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.